A high-throughput population screening laboratory sees significant scale-up with implementation of QIAGEN Clinical Insight (QCI®) INTRODUCTION Genetic disease is the leading...

Sean Scott, QIAGEN’s Chief Business Officer and Vice President of Business Development for Clinical Genomics and Bioinformatics, discusses the N-of-One...

[metaslider id=19676] With great networking opportunities, exciting panel discussions, and a packed exhibit hall, Precision Medicine World Conference 2019 was...

HGMD® Professional version 2018.4 contains a total of 248,700 mutations entries—that’s 8,431 more mutation entries than the previous release! Unlike other...

Fall is in full swing, and 2019 is fast approaching! Here's a look at some of the top bioinformatics-adjacent stories...

The industry’s top contenders went head-to-head in this year’s Battle of the Bioinformatics Pipelines at AMP Europe 2018. Variants were...

This July, we’re holding a special webinar series event showcasing a variety of aspects of NGS technology. Our wet-bench experts...

Not too long ago, we returned from Oxford Global’s 8th Annual NGS Congress. While the majestic host city of London was...

This years Annual Next Generation Sequencing Congress is taking place on November 10-11 in London, UK. Developments in NGS technologies and platforms,...

Recently the Journal of Precision Medicine ran a compelling article by Valentin Barsan, MD, about the increasing relevance of next-generation...